BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22641255)

  • 1. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
    Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
    Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of individuals living with spinal cord injury toward preference-based quality of life instruments: a qualitative exploration.
    Whitehurst DG; Suryaprakash N; Engel L; Mittmann N; Noonan VK; Dvorak MF; Bryan S
    Health Qual Life Outcomes; 2014 Apr; 12():50. PubMed ID: 24731409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health state descriptions, valuations and individuals' capacity to walk: a comparative evaluation of preference-based instruments in the context of spinal cord injury.
    Whitehurst DGT; Mittmann N; Noonan VK; Dvorak MF; Bryan S
    Qual Life Res; 2016 Oct; 25(10):2481-2496. PubMed ID: 27098235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "When I saw walking I just kind of took it as wheeling": interpretations of mobility-related items in generic, preference-based health state instruments in the context of spinal cord injury.
    Michel YA; Engel L; Rand-Hendriksen K; Augestad LA; Whitehurst DG
    Health Qual Life Outcomes; 2016 Nov; 14(1):164. PubMed ID: 27894349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.
    Mukuria C; Rowen D; Harnan S; Rawdin A; Wong R; Ara R; Brazier J
    Appl Health Econ Health Policy; 2019 Jun; 17(3):295-313. PubMed ID: 30945127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
    Richardson J; Khan MA; Iezzi A; Maxwell A
    Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
    Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores.
    Whitehurst DG; Bryan S; Lewis M
    Med Decis Making; 2011; 31(6):E34-44. PubMed ID: 21993430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of preference-based measures for the assessment of quality of life in children and adolescents with cerebral palsy.
    Mpundu-Kaambwa C; Chen G; Huynh E; Russo R; Ratcliffe J
    Qual Life Res; 2018 Jul; 27(7):1781-1799. PubMed ID: 29569017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.
    Gamst-Klaussen T; Chen G; Lamu AN; Olsen JA
    Qual Life Res; 2016 Jul; 25(7):1667-78. PubMed ID: 26687615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring psychometric properties of the SF-6D, a preference-based health-related quality of life measure, in the context of spinal cord injury.
    Engel L; Bryan S; Evers SM; Dirksen CD; Noonan VK; Whitehurst DG
    Qual Life Res; 2014 Oct; 23(8):2383-93. PubMed ID: 24700379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study.
    Pickles K; Lancsar E; Seymour J; Parkin D; Donaldson C; Carter SM
    Soc Sci Med; 2019 Nov; 240():112560. PubMed ID: 31563007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of the Development and Application of Generic Preference-Based Instruments with the Older Population.
    Cleland J; Hutchinson C; Khadka J; Milte R; Ratcliffe J
    Appl Health Econ Health Policy; 2019 Dec; 17(6):781-801. PubMed ID: 31512086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews.
    Finch AP; Brazier JE; Mukuria C
    Eur J Health Econ; 2018 May; 19(4):557-570. PubMed ID: 28560520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.